| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Pelthos Therapeutics Inc. | Chief Commercial Officer | Stock Option | 93,000 | 02 Jul 2025 | Direct | ||
| Pelthos Therapeutics Inc. | Chief Commercial Officer | Restricted Stock Units | 30,518 | 02 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CHRO | Pelthos Therapeutics Inc. | 02 Jul 2025 | 2 | $0 | 4 | Chief Commercial Officer | 21 Jul 2025, 20:26 |
| CHRO | Pelthos Therapeutics Inc. | 02 Jul 2025 | 0 | $0 | 3 | Chief Commercial Officer | 21 Jul 2025, 20:25 |